{
    "organizations": [],
    "uuid": "e8a6f52341f3f383dda9294190d1df491c8cd729",
    "author": "",
    "url": "https://www.reuters.com/article/impax-labs-lawsuit/impax-reaches-20-mln-deal-to-end-trial-over-generic-drugs-delay-idUSL1N1RB0UW",
    "ord_in_thread": 0,
    "title": "Impax reaches $20 mln deal to end trial over generic drug's delay",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 29, 2018 / 1:51 PM / in 15 minutes Impax reaches $20 mln deal to end trial over generic drug's delay Reuters Staff 1 Min Read \nBOSTON, March 29 (Reuters) - Impax Laboratories Inc has agreed to pay $20 million to consumers and insurers to resolve claims that the drugmaker entered an anticompetitive deal to delay launching a generic, cheaper version of acne medication Solodyn. \nThe accord, disclosed in papers filed in federal court in Boston, brought to an end a rare trial in a class action lawsuit involving an alleged “pay-for-delay” patent litigation settlement between a brand-name drugmaker and a generic company. (Reporting by Nate Raymond in Boston Editing by Chizu Nomiyama)",
    "published": "2018-03-29T16:50:00.000+03:00",
    "crawled": "2018-03-29T17:17:15.000+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "pm",
        "minute",
        "impax",
        "reach",
        "mln",
        "deal",
        "end",
        "trial",
        "generic",
        "drug",
        "delay",
        "reuters",
        "staff",
        "min",
        "read",
        "boston",
        "march",
        "reuters",
        "impax",
        "laboratory",
        "inc",
        "agreed",
        "pay",
        "million",
        "consumer",
        "insurer",
        "resolve",
        "claim",
        "drugmaker",
        "entered",
        "anticompetitive",
        "deal",
        "delay",
        "launching",
        "generic",
        "cheaper",
        "version",
        "acne",
        "medication",
        "solodyn",
        "accord",
        "disclosed",
        "paper",
        "filed",
        "federal",
        "court",
        "boston",
        "brought",
        "end",
        "rare",
        "trial",
        "class",
        "action",
        "lawsuit",
        "involving",
        "alleged",
        "patent",
        "litigation",
        "settlement",
        "drugmaker",
        "generic",
        "company",
        "reporting",
        "nate",
        "raymond",
        "boston",
        "editing",
        "chizu",
        "nomiyama"
    ]
}